Delivery Order SPE2DB22D2206-SPE2DB25FJY96
- Not listed
- The Defense Logistics Agency awarded a $14,221.60 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a specialized oncology medication, with performance at the contractor's Conshohocken, Pennsylvania location. The contract is structured as a firm fixed-price delivery order under a non-competitive set-aside, with an ultimate completion date of October 3, 2025. This award represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $17,777 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a oncology therapeutic agent used in cancer treatment. The contract was competitively awarded without set-aside restrictions and carries an ultimate completion date of September 24, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency's Medical Supply Chain awarded a $53,331 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a oncology therapeutic agent. The contract was competitively awarded without set-aside provisions and is scheduled for completion by September 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $17,777.00 to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a cancer therapeutic agent. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,443.90 for 100 mg vials of Enhertu, a oncology therapeutic agent, with performance in Conshohocken, Pennsylvania and completion scheduled for May 13, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order executes...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $17,777.00 for 100 mg vials of Enhertu, a oncology therapeutic agent used in cancer treatment. This firm fixed-price, competitively awarded contract was issued by the Defense Logistics Agency Medical Supply Chain on August 14, 2025, with a completion date of September 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $17,777.00 delivery order to AmerisourceBergen Drug Corp for 100 milligram vials of Enhertu, a specialty oncology medication. This firm fixed price contract, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with the federal government. The award was competitively granted without set-aside provisions and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $14,221.60 to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a specialty oncology medication, with performance in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on August 6, 2025, was competitively awarded without set-aside designation and is scheduled for completion by August 27, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $10,666.20 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a prescription oncology medication used in cancer treatment. This firm fixed-price delivery order, issued on August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $8,888.50 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with an ultimate completion date of October 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on September 16, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJY96Delivery Order
The Defense Logistics Agency awarded a $17,777.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a oncology therapeutic medication used in cancer treatment. The contract was competitively awarded without a set-aside designation and is scheduled for completion by October 8, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement needs. The company fulfills orders through DLA's Medical Supply Chain, delivering a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Enhertu delivery exemplifies the company's role in supplying specialized oncology therapeutics to military healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 9/17/25 |